The Latest Cardiac and Vascular News
EDEN PRAIRIE, Minn., May 29, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on May 23, 2019, the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to five individuals entering into employment with the Company. The equity awards […]
WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced a $25 million financing with Vensana Capital as the lead investor. Vensana was joined by existing investors including New Enterprise Associates (“NEA”), H.I.G. BioHealth Partners, and Quaker Partners. The Company reported closure […]
WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced a $37 million financing with Vensana Capital and Gilde Healthcare as lead investors. They were joined by existing investors New Enterprise Associates (“NEA”) and Quaker Partners. The first tranche of the financing […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that it has named Dana G. Mead, Jr. as President and Chief Executive Officer (CEO). Mead also has been appointed to HeartFlow’s Board of Directors. Former President and CEO John H. Stevens, M.D., will continue to serve on the Board of Directors and […]
Xellera Therapeutics Limited will accelerate the progression of Novoheart’s current business scope Significantly enhances Novoheart’s liquidity, gaining access to approximately C$22,500,000 cash VANCOUVER, British Columbia, May 28, 2019 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announced that effective on May 27, 2019, it has entered into […]
MARLBOROUGH, Mass., May 28, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the completion of a $55 million round of financing. The company’s current syndicate of institutional investors participated in the financing, and included senior debt financing from Kennedy Lewis Investment Management (“Kennedy Lewis“). […]
COPENHAGEN, Denmark, May 27, 2019 /PRNewswire/ — CathVision ApS, a medical device company developing, manufacturing and selling cardiac amplifier and electrophysiology products, announced today the addition of two industry leaders to its Board of Directors. Søren Thestrup-Nielsen, MD, was elected Chairman of the Board, and Denis Gestin was elected Member of the Board. Soren Thestrup-Nielsen, […]
LAVAL, Québec, May 23, 2019 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has completed the previously disclosed issuance of 900,000 common shares from treasury to its former chief executive officer (the “Former CEO”) pursuant to the terms of a settlement agreement […]
Rouen, France, May 21, 2019 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces today that Pr Haude, Dr Lorgat and Pr Nef have joined its medical advisory board. All are global experts and recognized leaders in interventional cardiology. The board […]
Q4 Revenue of $8.1 Billion, Flat as Reported and Grew 3.6% Organic Q4 GAAP Diluted EPS of $0.87; Q4 Non-GAAP Diluted EPS of $1.54 FY19 Revenue of $30.6 Billion Grew 2.0% Reported and 5.5% Organic FY19 GAAP Diluted EPS of $3.41; FY19 Non-GAAP Diluted EPS of $5.22 FY19 Cash Flow […]
